Get started
Author

Evelien P. Mauser‐Bunschoten

Observed names: Evelien Mauser-Bunschoten, Evelien Mauser‐Bunschoten, Evelien P Mauser-Bunschoten, Evelien P. Mauser-Bunschoten, Mauser-Bunschoten, E., Mauser-Bunschoten, E. P., Mauser-Bunschoten, E.P., Mauser-Bunschoten, Evelien, Mcrae, S.
OpenAlex ID: A5048888596
Factor VIII gene (F8) mutation and risk of inhibitor development in nonsevere hemophilia A
2013 · Corien L. Eckhardt, Alice S. van Velzen, et al. · Blood · 224
PDF
How I treat age-related morbidities in elderly persons with hemophilia
2009 · Pier M. Mannucci, Roger E. G. Schutgens, et al. · Blood · 184
Inhibition of fibrinolysis by recombinant factor VIIa in plasma from patients with severe hemophilia A
2002 · Ton Lisman, Laurent O. Mosnier, et al. · Blood · 155
The Half-life of Infused Factor VIII Is Shorter in Hemophiliac Patients with Blood Group 0 than in those with Blood Group A
2000 · Evelien Mauser-Bunschoten, Antoanette Zarkova, et al. · Thrombosis and Haemostasis · 116
Mortality, life expectancy, and causes of death of persons with hemophilia in the Netherlands 2001–2018
2020 · Shermarke Hassan, Rory C. Monahan, et al. · Journal of Thrombosis and Haemostasis · 102
PDF
IgG subclasses of anti‐FVIII antibodies during immune tolerance induction in patients with hemophilia A
2008 · Pauline M. W. van Helden, H. Marijke van den Berg, et al. · British Journal of Haematology · 98
PDF
Antifibrinolytic therapy for preventing oral bleeding in patients with haemophilia or Von Willebrand disease undergoing minor oral surgery or dental extractions
2015 · Karin PM van Galen, Eveline T Engelen, et al. · Cochrane Database of Systematic Reviews · 84
PDF
The combination of the biomarkers urinary C‐terminal telopeptide of type II collagen, serum cartilage oligomeric matrix protein, and serum chondroitin sulfate 846 reflects cartilage damage in hemophilic arthropathy
2008 · Nathalie W. D. Jansen, Goris Roosendaal, et al. · Arthritis & Rheumatism · 80
Bleeding spectrum in children with moderate or severe von W illebrand disease: R elevance of pediatric‐specific bleeding
2015 · Yvonne V. Sanders, Karin Fijnvandraat, et al. · American Journal of Hematology · 65
PDF
Nonacog beta pegol (N9-GP) in haemophilia B: A multinational phase III safety and efficacy extension trial (paradigm™4)
2016 · Guy Young, Peter W. Collins, et al. · Thrombosis Research · 61
Antifibrinolytic therapy for preventing oral bleeding in people on anticoagulants undergoing minor oral surgery or dental extractions
2018 · Eveline T Engelen, Roger EG Schutgens, et al. · Cochrane Database of Systematic Reviews · 56
PDF
Discontinuing early prophylaxis in severe haemophilia leads to deterioration of joint status despite low bleeding rates
2016 · Annelies Nijdam, Wouter Foppen, et al. · Thrombosis and Haemostasis · 50
Health and treatment outcomes of patients with hemophilia in the Netherlands, 1972–2019
2021 · Shermarke Hassan, Erna C. van Balen, et al. · Journal of Thrombosis and Haemostasis · 44
PDF
Antifibrinolytic therapy for preventing oral bleeding in patients with haemophilia or Von Willebrand disease undergoing minor oral surgery or dental extractions
2019 · Karin PM van Galen, Eveline T Engelen, et al. · Cochrane Database of Systematic Reviews · 41
PDF
Viral hepatitis in haemophilia: historical perspective and current management
2021 · Cas J. Isfordink, Karel J. van Erpecum, et al. · British Journal of Haematology · 28
PDF
Inhibitor incidence after intensive FVIII replacement for surgery in mild and moderate haemophilia A : a prospective national study in the N etherlands
2012 · Corien L. Eckhardt, Evelien P. Mauser‐Bunschoten, et al. · British Journal of Haematology · 28
Circulating Angiogenic Mediators in Patients with Moderate and Severe von Willebrand Disease: A Multicentre Cross-Sectional Study
2018 · Dafna Groeneveld, Yvonne Sanders, et al. · Thrombosis and Haemostasis · 17
Management of cardiovascular disease in aging persons with haemophilia
2016 · Michiel Voskuil, Evelien Mauser-Bunschoten, et al. · Hämostaseologie · 17
Desmopressin treatment combined with clotting factor VIII concentrates in patients with non-severe haemophilia A: protocol for a multicentre single-armed trial, the DAVID study
2019 · Lisette M Schütte, Marjon H Cnossen, et al. · BMJ Open · 12
PDF
Socioeconomic participation of persons with hemophilia: Results from the sixth hemophilia in the Netherlands study
2022 · Erna C. van Balen, Shermarke Hassan, et al. · Research and Practice in Thrombosis and Haemostasis · 10
PDF
Abstracts
2016 · de Kleijn, Piet, Sluiter, David, et al. · Haemophilia · 8
PDF
Antifibrinolytic therapy for preventing oral bleeding in patients with a hemophilia or Von Willebrand disease undergoing oral or dental procedures
2014 · Karin PM van Galen, Eveline T Engelen, et al. · Cochrane Database of Systematic Reviews · 7
[Von Willebrand disease in the Netherlands: the WiN study].
2014 · Yvonne V Sanders, Eva M de Wee, et al. · PubMed · 7
Abstracts
2014 · Eckhardt, C.L., Loomans, J.I., et al. · Haemophilia · 6
Liver‐related complications before and after successful treatment of chronic hepatitis C virus infection in people with inherited bleeding disorders
2022 · Cas J. Isfordink, Karel J. van Erpecum, et al. · Haemophilia · 5
PDF
Works count: 45
Citation count: 1,533
H-index: 17
I10-index: 20
Year
Topic
Type